← Back to Clinical Trials
Recruiting NCT07442656

NCT07442656 Frailty and Outcomes in Older Emergency Department Patients With Pneumonia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07442656
Status Recruiting
Phase
Sponsor Ege University
Condition Community-Acquired Pneumonia
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2026-01-01
Primary Completion 2026-03-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Clinical frailty scaleClinical Frailty Scale (CFS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2026-01-01 with a primary completion date of 2026-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pneumonia is one of the leading causes of infection-related mortality in the older population. Traditional severity scores used in emergency departments, such as the Pneumonia Severity Index (PSI) and CURB-65, primarily focus on acute physiological derangements and may not adequately capture biological reserve and frailty in older adults. Frailty is a geriatric syndrome reflecting increased vulnerability to stressors and reduced recovery capacity. This prospective observational cohort study aims to evaluate the predictive value of the Clinical Frailty Scale (CFS) for in-hospital mortality, 30-day mortality, and morbidity in patients aged 65 years and older presenting to the emergency department with pneumonia. Additionally, the study will assess whether incorporating frailty assessment into existing pneumonia severity scores improves prognostic accuracy.

Eligibility Criteria

Inclusion Criteria: * Age ≥65 years * Clinical and radiological diagnosis of pneumonia in the emergency department * Ability to obtain informed consent from the patient or legal representative * Availability of a caregiver or relative able to describe baseline functional status Exclusion Criteria: * Presentation with cardiopulmonary arrest or ongoing cardiopulmonary resuscitation at admission * Confirmed COVID-19 pneumonia * Inability to obtain reliable baseline functional history due to absence of an informant * Refusal to provide informed consent

Contact & Investigator

Central Contact

Özlem İnci, MD

✉ ozge.can@ege.edu.tr

📞 902323902321

Frequently Asked Questions

Who can join the NCT07442656 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Community-Acquired Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07442656 currently recruiting?

Yes, NCT07442656 is actively recruiting participants. Contact the research team at ozge.can@ege.edu.tr for enrollment information.

Where is the NCT07442656 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT07442656 clinical trial?

NCT07442656 is sponsored by Ege University. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology